Jianqiang Wang

USPTO Granted Patents = 11 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 111(Granted Patents)

Location History:

Woburn, MA (US) (2010)
Acton, WA (US) (2013)
Acton, MA (US) (2009 - 2015)

Company Filing History:

Triad Liquidating Company, LLC

patents

Years Active: 2009-2015

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9012466 - Substituted tricyclic pyrazolo-pyrimidine compounds (2015-04-21),

2. 8580803 - Substituted pyrrolo-aminopyrimidine compounds (2013-11-12),

3. 8563567 - Substituted heterocyclic compounds (2013-10-22),

4. 8513292 - Compositions and methods for the treatment of cancer (2013-08-20),

5. 8410144 - Substituted indolo-pyridinone compounds (2013-04-02),

6. 8343983 - Substituted pyrazolo-pyrimidine compounds (2013-01-01),

7. 8304425 - Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer (2012-11-06),

8. 8263610 - Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds (2012-09-11),

9. 7964534 - Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes (2011-06-21),

10. 7652044 - P-38 inhibitors (2010-01-26),

11. 7569571 - Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators (2009-08-04),

Title: Innovations of Jianqiang Wang

Introduction

Jianqiang Wang is a prominent inventor based in Acton, MA, with a remarkable portfolio of 11 patents. His work primarily focuses on pharmaceutical compounds that have significant implications for treating cell proliferative disorders, including cancer.

Latest Patents

Among his latest innovations are the substituted tricyclic pyrazolo-pyrimidine compounds. This invention relates to the synthesis of these compounds and their use in pharmaceutical compositions aimed at treating various cell proliferative disorders. Another notable patent is for substituted pyrrolo-aminopyrimidine compounds, which also includes methods for synthesizing these compounds and their application in treating similar disorders.

Career Highlights

Jianqiang Wang has made significant contributions to the field of pharmaceuticals through his work at notable companies such as Arqule, Inc. and Novartis AG. His expertise in developing innovative compounds has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Jianqiang has collaborated with talented individuals, including Nivedita Namdev and Mark Anthony Ashwell, enhancing the scope and impact of his research.

Conclusion

Jianqiang Wang's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science and improving treatment options for serious health conditions. His work continues to inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.